Heroin Dependence
70
0
0
49
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
13 trials with published results (19%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
3 terminated out of 70 trials
94.2%
+7.7% vs benchmark
23%
16 trials in Phase 3/4
27%
13 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 49 completed trials
Clinical Trials (70)
Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder
Change the Cycle: An RCT to Prevent Injection Initiation
Biomarkers of Injectable Extended Release Naltrexone Treatment
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence
Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
Study of Computer-Based Treatment for Drug Dependence
Laser Meridian Massage in Heroin Addicts
Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts
Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
University of Houston Drug Abuse Research Development Program II
Memantine as a Supplement to Naltrexone in Treating Heroin Dependence
Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1
The Therapeutic Workplace Initiation Study